Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients (original) (raw)

Effort blood pressure control in the course of antihypertensive treatment

MARIO AUSIELLO

The American Journal of Medicine, 1989

View PDFchevron_right

Antihypertensive Therapies and Left Ventricular Hypertrophy

Elsayed Z Soliman

Current Hypertension Reports, 2017

View PDFchevron_right

Current Treatment of Patients with Hypertension

Stefano Taddei

Drugs, 2003

View PDFchevron_right

Value of haemodynamic profiling to the response of antihypertensive therapy

Maksim Zagura

Artery Research, 2014

View PDFchevron_right

Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension

Wille Oigman

The American Journal of Cardiology, 1984

View PDFchevron_right

Changing Concepts in the Management of Hypertension

Andrew Hua

Medical Journal of Australia, 1975

View PDFchevron_right

Potassium-Sparing Diuretics in Hypertension

Leonardo Sechi

Antihypertensive Drugs, 2012

View PDFchevron_right

Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension

Julius Gardin

The American Journal of Medicine, 1983

View PDFchevron_right

Drugs in the management of hypertension. Part I

Henry Yager

American Heart Journal, 1976

View PDFchevron_right

Antihypertensive therapy and arterial function in experimental hypertension

Pertti Arvola

General pharmacology, 1996

View PDFchevron_right

Differential pulse pressure response to various antihypertensive drug families

Dennis Cokkinos

Journal of Human Hypertension, 2006

View PDFchevron_right

Antihypertensive Therapy in Patients Above Age 60 with Systolic Hypertension

P. Willemse

Clinical and Experimental Hypertension, 1982

View PDFchevron_right

NEW DESIGN FOR CLINICAL TRIAL OF ANTIHYPERTENSIVE DRUGS APPLIED TO PINDOLOL, CLOPAMIDE, AND COMBINATIONS THEREOF

Jerzy Leppert

The Lancet, 1982

View PDFchevron_right

Persistent Sympathetic Activation During Chronic Antihypertensive Therapy A Potential Mechanism for Long Term Morbidity

Anand prasad

View PDFchevron_right

Natriuretic effect of rilmenidine in anesthetized rats

Joost van der Mark

1994

View PDFchevron_right

Influence of ATII blockers and calcium channel blockers on renal vascular resistance in patients with essential hypertension

Kresimir Galesic

Collegium Antropologicum, 2009

View PDFchevron_right

Patterns of left ventricular hypertrophy in essential hypertension: Should echocardiography guide the pharmacological treatment

Maite Gonzalez

International Journal of Cardiology, 2008

View PDFchevron_right

Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension

Juliana Chan

American Heart Journal, 1997

View PDFchevron_right

Effects of rilmenidine on 24-h rhythmicity of blood pressure and spontaneous baroreflex sensitivity in essential hypertensive subjects

Dominique Laude

Journal of Hypertension, 2006

View PDFchevron_right

Management of patients with resistant hypertension: current treatment options

Tanja Dudenbostel

Integrated Blood Pressure Control, 2013

View PDFchevron_right

Actions of rilmenidine on neurogenic hypertension in BPH/2J genetically hypertensive mice

Geoffrey Head

Journal of Hypertension, 2014

View PDFchevron_right

Effects of chronic sympatho-inhibition on renal excretory function in renovascular hypertension

Geoffrey Head

Journal of Hypertension, 2011

View PDFchevron_right

First-line pharmacological treatment of hypertension

Michel Burnier

Journal of Internal Medicine, 1992

View PDFchevron_right

Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension

maurizio castellano

American Journal of Cardiology, 1982

View PDFchevron_right

Pharmacological treatment for the systemic hypertension: analysis of a group of hypertensive patients

Germana Silveira

Journal of Nursing Ufpe Online, 2015

View PDFchevron_right

Contemporary antihypertensive therapy

Andrew Zweifler

Survey of ophthalmology

View PDFchevron_right

Baroreflex Function in Hypertension: Consequences for Antihypertensive Therapy

Guido Grassi

Progress in Cardiovascular Diseases, 2006

View PDFchevron_right

Role of Cardiac and Vascular Amplifiers in the Maintenance of Hypertension and the Effect of Reversal of Cardiovascular Hypertrophy

Murray Esler

Clinical and Experimental Pharmacology and Physiology, 1985

View PDFchevron_right

Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study

Hakan Gocer

Current Therapeutic Research, 2003

View PDFchevron_right

Combination Angiotensin Receptor Blocker/Hydrochlorothiazide as Initial Therapy in the Treatment of Patients With Severe Hypertension

Robin Mukherjee

The Journal of Clinical Hypertension, 2004

View PDFchevron_right

Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH

Maurizio Abrignani

American journal of hypertension, 2001

View PDFchevron_right

Association of antihypertensive monotherapy with serum sodium and potassium levels in Chinese patients Word count: Text: 2,170

Stewart Mercer

2000

View PDFchevron_right

Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension

Ehud Grossman

The American Journal of Cardiology, 1988

View PDFchevron_right

Renal and systemic hemodynamics in sustained essential hypertension

Michel Safar, GĂ©rard London

Hypertension, 1984

View PDFchevron_right

Analysis of Recent Papers in Hypertension Jan Basile, MD, Senior Editor

Jan Basile

The Journal of Clinical Hypertension, 2008

View PDFchevron_right